Insiders · Profile

SHERMAN JEFFREY W

Director at Larimar Therapeutics · Director at Xeris Biopharma. Filing since 27 Nov 2023. CIK 0001230482

Company
Date
Role
Action
Shares
Amount
Of holding
27 Feb 2026
Director
Bought
5,000
$25.00K
opened
28 Aug 2025
Director
Sold at will
42,232
$334.52K
16.2%
27 Nov 2023
Director
Bought
5,400
$10.10K
opened
3 decisions on file.